Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel

Updated on: February 20,2024

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel

Updated on:February 20,2024

New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

by Delthia Ricks , Medical XpressAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainMedical investigators are theorizing that a combination of t

Updated on: January 25,2024

New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

by Delthia Ricks , Medical XpressAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainMedical investigators are theorizing that a combination of t

Updated on:January 25,2024

Something in the water? Researchers studying large number of late-stage breast cancer cases in Florida county

by Cindy Krischer GoodmanCredit: Unsplash/CC0 Public DomainBroward County, Florida's rate of advanced breast cancer exceeds the state and national average, and researchers want to learn why.Could

Updated on: January 04,2024

Something in the water? Researchers studying large number of late-stage breast cancer cases in Florida county

by Cindy Krischer GoodmanCredit: Unsplash/CC0 Public DomainBroward County, Florida's rate of advanced breast cancer exceeds the state and national average, and researchers want to learn why.Could

Updated on:January 04,2024

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on: December 25,2023

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on:December 25,2023

A silent killer, liver cancer prompts race to improve organ replacements

by Anthony King,Horizon: The EU Research & Innovation MagazineBioprinter from Organtrans. Credit: © Gilles WederWith the only cure for liver cancer often being a transplantation, scientists

Updated on: December 22,2023

A silent killer, liver cancer prompts race to improve organ replacements

by Anthony King,Horizon: The EU Research & Innovation MagazineBioprinter from Organtrans. Credit: © Gilles WederWith the only cure for liver cancer often being a transplantation, scientists

Updated on:December 22,2023

Scientists discover metabolic feature that allows melanoma cells to spread

by Katie Regan,UT Southwestern Medical CenterResearchers involved in the study include (from left) Drs. Brandon Faubert, Alpaslan Tasdogan, Sean Morrison, and Ralph DeBerardinis. Credit: UTSWRes

Updated on: December 23,2023

Scientists discover metabolic feature that allows melanoma cells to spread

by Katie Regan,UT Southwestern Medical CenterResearchers involved in the study include (from left) Drs. Brandon Faubert, Alpaslan Tasdogan, Sean Morrison, and Ralph DeBerardinis. Credit: UTSWRes

Updated on:December 23,2023

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on: December 22,2023

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on:December 22,2023

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Updated on: December 26,2023

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Updated on:December 26,2023

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on: March 30,2024

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on:March 30,2024

First map of circular DNA in childhood cancer

byCharité - Universitätsmedizin BerlinDNA of a neuroblastoma cell: Between the chromosomes (blue) there are numerous small DNA rings (green). The centromere of chromosome 2 is stained red. Credi

Updated on: December 22,2023

First map of circular DNA in childhood cancer

byCharité - Universitätsmedizin BerlinDNA of a neuroblastoma cell: Between the chromosomes (blue) there are numerous small DNA rings (green). The centromere of chromosome 2 is stained red. Credi

Updated on:December 22,2023

Study finds 95 percent satisfaction rate with Mohs surgery

by Patrick McGee,UT Southwestern Medical CenterPatients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with

Updated on: December 20,2023

Study finds 95 percent satisfaction rate with Mohs surgery

by Patrick McGee,UT Southwestern Medical CenterPatients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with

Updated on:December 20,2023

Less than half of pregnant women get the flu shot: New data from UPMC Children's might change that

by Abby Mackey, Pittsburgh Post-GazetteCredit: Unsplash/CC0 Public DomainJohn Williams knows the risks associated with riding motorcycles, but they don't deter him. Neither do warnings from physic

Updated on: March 25,2024

Less than half of pregnant women get the flu shot: New data from UPMC Children's might change that

by Abby Mackey, Pittsburgh Post-GazetteCredit: Unsplash/CC0 Public DomainJohn Williams knows the risks associated with riding motorcycles, but they don't deter him. Neither do warnings from physic

Updated on:March 25,2024